The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease.
Flavor test
Olfaction
Parkinson’s disease
Taste
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
02
01
2019
accepted:
12
03
2019
pubmed:
22
3
2019
medline:
14
1
2020
entrez:
22
3
2019
Statut:
ppublish
Résumé
Gustatory perception has been poorly explored in Parkinson's disease (PD). Aim of this study was to assess the flavor ability in PD patients, using the "flavor test" (FT), a new standardized and validated tool to examine the flavor perception. Thirty-eight patients (17 F and 21 M) and 36 control subjects (15 F and 21 M) comparable for age and gender were enrolled. All the subjects underwent the flavor test (FT), the Sniffin' Sticks test (SST), and the gustometry test (GT), based on the basic four tastants ("salty," "sour," "sweet," and "bitter"). PD patients presented a FT score significantly lower than controls (p < 0.001). Olfaction (SST) was impaired in PD in comparison with controls (p < 0.001), and the patients also showed a mild reduction of basic tastant identification at the GT (p = 0.08), with a trend toward statistical significance. There was no correlation between SST, FT, and GT. GT performance was negatively correlated with disease severity (p = 0.004) and stage (p = 0.024). The SST and FT resulted abnormal in PD in comparison with controls, independently of disease duration and severity. The ability to identify the basic four tastants was correlated with the disease severity and stage in PD patients suggesting that it might occur later in the course of the disease. FT might be a sensitive tool in identifying the sensorineural perception dysfunction in PD, even in the early stage and regardless of the disease severity.
Identifiants
pubmed: 30895397
doi: 10.1007/s10072-019-03842-2
pii: 10.1007/s10072-019-03842-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1351-1356Références
Eur Arch Otorhinolaryngol. 2000;257(4):205-11
pubmed: 10867835
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Arch Neurol. 2003 May;60(5):667-71
pubmed: 12756129
Mov Disord. 2005 Apr;20(4):471-5
pubmed: 15597336
Exp Brain Res. 2005 Oct;166(3-4):345-57
pubmed: 16028032
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43
pubmed: 17021776
Parkinsonism Relat Disord. 2007;13 Suppl 3:S225-8
pubmed: 18267240
Parkinsonism Relat Disord. 2009 Mar;15(3):232-7
pubmed: 18606556
Mov Disord. 2008 Oct 30;23(14):1984-90
pubmed: 18759360
Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1911-7
pubmed: 20495925
QJM. 2010 Dec;103(12):941-52
pubmed: 20736182
J Neurol Sci. 2013 Jun 15;329(1-2):17-22
pubmed: 23561981
J Neuropathol Exp Neurol. 2013 Jun;72(6):524-39
pubmed: 23656994
PLoS One. 2013 May 16;8(5):e64735
pubmed: 23696904
Gastroenterology. 2013 Sep;145(3):537-9.e3
pubmed: 23714381
J Neural Transm (Vienna). 2014 Feb;121(2):119-22
pubmed: 24078166
J Neurol. 2014 Jan;261(1):180-7
pubmed: 24190794
Neurology. 2015 May 26;84(21):2107-15
pubmed: 25925983
Endocrine. 2016 May;52(2):236-43
pubmed: 26209039
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Neuropathol Appl Neurobiol. 2016 Feb;42(1):33-50
pubmed: 26662475
J Neural Transm (Vienna). 2017 Mar;124(3):347-352
pubmed: 27812756
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
Int Rev Neurobiol. 2017;133:541-556
pubmed: 28802932
Neurosci Bull. 2017 Oct;33(5):515-525
pubmed: 28831680
J Neural Transm (Vienna). 2018 Jun;125(6):925-930
pubmed: 29470631
Neurology. 1988 Aug;38(8):1237-44
pubmed: 3399075
Physiol Behav. 1987;41(4):353-6
pubmed: 3432387